SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-109138
Filing Date
2020-09-28
Accepted
2020-09-28 08:30:23
Documents
1
Period of Report
2020-09-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2031826-1_4.html 4  
1 OWNERSHIP DOCUMENT tm2031826-1_4.xml 4 7565
  Complete submission text file 0001104659-20-109138.txt   9186
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Issuer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CAPRICOR THERAPEUTICS, INC. 8840 WILSHIRE BLVD., 2ND FLOOR BEVERLY HILLS CA 90211
Business Address
Manzo Louis (Reporting) CIK: 0001593100 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34058 | Film No.: 201202139